Quick Answer
Acadia Healthcare Company, Inc. reported Total Revenue of $3.31 billion for fiscal year 2025.
Acadia Healthcare Company, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $3.31B +5.0% |
$3.15B +7.7% |
$2.93B +12.2% |
$2.61B +12.8% |
$2.31B +10.7% |
$2.09B +4.1% |
| Revenue (ASC 606) | $3.31B +5.0% |
$3.15B +7.7% |
$2.93B +12.2% |
$2.61B +12.8% |
$2.31B +10.7% |
$2.09B +4.1% |
| Net Income | -$1.10B -531.4% |
$255.61M +1279.7% |
-$21.67M -107.9% |
$273.14M +43.3% |
$190.63M +128.4% |
-$672.13M -717.1% |
| Diluted EPS | -$12.16 -537.4% |
$2.78 +1258.3% |
-$0.24 -108.1% |
$2.98 +41.9% |
$2.10 +127.7% |
-$7.59 -712.1% |
| Total Assets | $5.53B -7.2% |
$5.96B +11.2% |
$5.36B +7.4% |
$4.99B +4.6% |
$4.77B -26.6% |
$6.50B -5.5% |
| Cash and Equivalents | $133.24M +74.6% |
$76.31M -23.8% |
$100.07M +2.5% |
$97.65M -27.0% |
$133.81M -64.7% |
$378.70M +280.5% |
| Long-Term Debt | $2.47B +31.5% |
$1.88B +40.0% |
$1.34B -1.6% |
$1.36B -7.7% |
$1.48B -50.2% |
$2.97B -4.4% |
| Stockholders Equity | $1.95B -36.6% |
$3.07B +10.5% |
$2.78B -1.1% |
$2.81B +11.7% |
$2.52B +32.5% |
$1.90B -24.2% |
| Shares Outstanding | 90.45M -1.4% |
91.78M +0.6% |
91.26M +1.5% |
89.91M +1.0% |
89.03M +1.1% |
88.02M +0.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $851.57M | +4.4% | -2.0% |
| Revenue (ASC 606) | September 30, 2025 | $851.57M | +4.4% | -2.0% |
| Net Income | September 30, 2025 | $36.25M | -46.8% | +20.3% |
| Diluted EPS | September 30, 2025 | $0.40 | -45.9% | +21.2% |
| Total Assets | September 30, 2025 | $6.41B | +9.2% | +1.7% |
| Cash and Equivalents | September 30, 2025 | $118.69M | +44.5% | -9.7% |
| Long-Term Debt | September 30, 2025 | $2.28B | +26.6% | +1.7% |
| Stockholders Equity | September 30, 2025 | $3.12B | +2.9% | +1.4% |
| Shares Outstanding | September 30, 2025 | 90.43M | -1.4% | +0.0% |
- Acadia Healthcare Company, Inc. reported Total Revenue of $3.31 billion for fiscal year 2025.
- Acadia Healthcare Company, Inc. showed an increase of +5.0% in Total Revenue compared to the prior fiscal year.
- Acadia Healthcare Company, Inc. reported Revenue (ASC 606) of $3.31 billion for fiscal year 2025.
- Acadia Healthcare Company, Inc. showed an increase of +5.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Acadia Healthcare Company, Inc. reported Net Income of -$1.10 billion for fiscal year 2025.
- Acadia Healthcare Company, Inc. showed a decrease of -531.4% in Net Income compared to the prior fiscal year.
- Acadia Healthcare Company, Inc. reported Diluted EPS of $12.16 per share (loss) for fiscal year 2025.
- Acadia Healthcare Company, Inc. showed a decrease of -537.4% in Diluted EPS compared to the prior fiscal year.
- Acadia Healthcare Company, Inc. reported Total Assets of $5.53 billion for fiscal year 2025.
- Acadia Healthcare Company, Inc. showed a decrease of -7.2% in Total Assets compared to the prior fiscal year.
- Acadia Healthcare Company, Inc. reported Cash and Equivalents of $133.24 million for fiscal year 2025.
- Acadia Healthcare Company, Inc. showed an increase of +74.6% in Cash and Equivalents compared to the prior fiscal year.
- Acadia Healthcare Company, Inc. reported Long-Term Debt of $2.47 billion for fiscal year 2025.
- Acadia Healthcare Company, Inc. showed an increase of +31.5% in Long-Term Debt compared to the prior fiscal year.
- Acadia Healthcare Company, Inc. reported Stockholders Equity of $1.95 billion for fiscal year 2025.
- Acadia Healthcare Company, Inc. showed a decrease of -36.6% in Stockholders Equity compared to the prior fiscal year.
- Acadia Healthcare Company, Inc. reported Shares Outstanding of 90.45 million shares for fiscal year 2025.
- Acadia Healthcare Company, Inc. showed a decrease of -1.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: